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ABSTRACT 
The aim of this study was to design and test key aspects of a novel device, 
consisting of a polymer referencing enclosure (hardware) and a gel component, for the 
standardization of intraoperative gross pathology examination of excised breast cancer 
tissue. The proposed device improves the current practice of tissue preparation for 
radiographic and pathological examination without changing the existing process and 
without imposing retraining requirements on professional staff involved in the current 
process. To identify the optimal composition of the gel component to be used, 32 gel 
formulations were tested to determine setting times and maximum temperature reached 
during setting. The radiographic properties of 12 gel formulations and 15 plastic 
materials for potential use in the hardware were also tested. A negative correlation was 
found to exist between setting time and maximum temperature reached, narrowing down 
gel selections to those setting in <10 minutes with a temperature peak of <54 °C. The 
radiographic properties of the tested and downselected gels and plastics were found to be 
such that these materials are unlikely to interfere with lesion identification in radiological 
examinations. A completed tissue study for examination of gel effects on tissue 
properties revealed no effects, thereby clearing this device for potential clinical 
applications. 
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I. CURRENT PROCEDURES USED IN TUMOR SPECIMEN PREPARATION 
In this section, we will begin with an overview of breast cancer progression, 
causes, and prevalence. Then, we will describe breast cancer treatment options, current 
technologies and practices used in treatments, and the subsequent limitations of these 
practices. This will provide a foundation for outlining our novel device solution and the 
affiliated studies that we performed. 
A. What is breast cancer and what is its cause? 
Breast cancer is a malignant group of cells located in the breast tissue that 
proliferates uncontrollably and has the potential to metastasize to other areas of the body 
(American Cancer Society, 2011). It is a disease that most prominently occurs in women 
due to the structure and functions of the tissues in the breast and affects over 4.3 million 
people worldwide (SEER, 2008). Figure 1.1 below illustrates the normal structure of a 
female breast. 
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Figure 1.1. Anatomy of the female breast (AMERICAN CANCER SOCIETY, 2011). 
Breast cancers are classified based on the characteristics of tissue of origin, 
invasiveness and disease progression. The majority of breast cancers begin in the milk 
ducts, responsible for carrying milk from the production sites, or lobules, to the nipple. In 
all forms of breast cancer, invasiveness is of high concern due to the proximity of the 
lymphatic system, the network of vessels through which lymph drains from the tissues 
into the blood, to the breast tissue. If the cancer spreads to the lymph nodes, the risk of 
metastasis is increased significantly because the lymphatic system facilitates transfer of 
cancerous cells to other areas of the body through the blood (American Cancer Society, 
2011). 
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Figure 1.2. Structure and organization of the lymphatic system in the breast tissue 
(AMERICAN CANCER SOCIETY, 2011). 
Like the majority of cancers, there is no known definitive cause of breast cancer. 
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Despite this, increased risk of breast cancer has been associated with the following: 
hormone replacement therapy (Rossouw JE, 2002), up-regulation of HER2 gene 
expression (Tzu-Chao, 2011) and overexpression ofIGF-I or IGF-I receptors (Kleinberg, 
2009), toxins such as atrazine (Simpkins, 2011 ), reproductive history (Russo, 2011 ), and 
germline mutations in genes such as BRCAl and BRCA2 (Hughes, 2008). 
Regardless of the predicted causes of disease progression, early detection is 
pertinent to survival and recovery. The most common methods of detecting the formation 
of breast tumors are through palpation, or manual breast examination, and radiographic 
screening. In both of these processes, the screener attempts to locate a hard lump with the 
fingers in examination or a dense mass using mammography; the look and feel of the 
tumor is often the result of microcalcifications, or characteristic clusters of calcium 
deposits. The formation of microcalcifications is most often due to one or more of the 
following: cysts in the breast tissue, cell secretions or debris, ductal carcinoma in situ, 
fibroadenoma, mammary duct ectasia, mastitis, or dermal vascular calcification (Mayo 
Clinic, 2011). However, not all breast cancers have high-contrast microcalcifications 
present. 
Early manifestations of breast cancer can be very subtle and are identified as a 
complex and variable pattern in contrast to normal anatomy (Vybomy, 2000). Early 
detection is heavily reliant on the radiologist's ability to identify characteristic lesions, 
sometimes at very low contrast to the surrounding tissue (Ishida, 1996). In order to 
increase the reliability of diagnosis, imaging modalities and computerized detection 
software are being improved and developed (Alexander, 2011) (Yuan-Zhi, 2011) (Felix, 
2011) (Dorrius, 2011) (Schmidt, 2011) (Vybomy, 2000). 
B. Treatment Approaches 
Surgical procedures 
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When a tumor is suspected to be present on a radiograph, a sample of breast tissue 
cells in the area of the suspicious mass is taken in a process called fine needle aspiration 
biopsy. To conduct this biopsy, a hollow needle is used to extract cells from the 
suspicious area of tissue, and then the fluid cell sample is tested and analyzed by a 
pathologist to determine the extent of malignancy. Surgical intervention is the most 
common first form of treatment when malignancy is found. 
Surgery is sometimes coupled with additional treatments such as radiation 
(Croshaw, 2011), chemotherapy (Kurbet, 2006), or thermal ablation (Zhao, 2010). 
Generally, the patient is must decide, with the physician's guidance, between modified 
radical mastectomy, the surgical removal of the all breast tissue and lymph nodes, or a 
lumpectomy, the removal of only the diseased tissue with a narrow rim of healthy tissue 
surrounding it. 
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Studies comparing the long-term results of radical mastectomy as compared to 
lumpectomy procedures have shown that there is no significant difference in overall 
survival between the two groups (Fisher B. B., 1985) (Fisher B. A., 1995) (Fisher B. A., 
2002). However, they also found that women undergoing lumpectomy with breast 
irradiation had statistically decreased incidence rates of recurrence in the ipsilateral breast 
as compared to lumpectomy alone (Fisher B. A., 2002). Some argue that a wider margin 
of healthy breast tissue surrounding the excised tumor would diminish this difference 
(Silverstein, 1999). 
Despite these encouraging statistics, with over 200,000 new cases of breast cancer 
diagnosed every year, half of patients eligible for lumpectomy still choose mastectomy. 
This is likely to be due to a one or more reasons including the following: physicians 
educated before the 1980s are more familiar with the procedures and results of 
mastectomies, insurance coverage of lumpectomies is not always available, socio-
economic factors, age of the patient, and the psychological well-being of feeling "safer" 
15 
against potential cancer recurrence (The Breast Care Site, 2011). Another major factor 
that affects patients' decisions is the incidence of repeat surgery following breast-
conserving surgery. Approximately one in three patients that choose breast-conserving 
procedures, such as lumpectomy, must have repeat surgery within weeks, sometimes 
resulting in up to four re-excision surgeries or a conversion to mastectomy (Brown, 2010) 
(Guenther, 1996) (Uecker, 2011). Furthermore, procedures lacking intraoperative 
assessment of tumor margins result in 60% likelihood that a patient has to return for a 
repeat surgical excision procedure (Uecker, 2011). These staggering statistics mean that 
tens of thousands of women each year return for multiple unnecessary high risk surgeries, 
a number that we aim to reduce. 
Our goal with this device is to provide a means by which pathologists can more 
accurately and easily assess tumor margins intraoperatively for the purpose of decreasing 
the incidence rate of repeat surgery and local recurrence and make breast-conserving 
surgery a viable option for more women. 
Pathology tumor margin analysis process & limitations 
Once the cancerous tissue is excised from a patient as part of the surgical 
treatment process, steps are taken to ensure that the entirety of the diseased tissue has 
been removed and to guide subsequent treatment protocols. The method by which 
complete removal of the tumor is determined is by analyzing whether there is cancer 
present near the margins of the excised tissue specimen; if there is cancerous tissue 
within 2 mm of the edge of the tissue, it is identified as a 'positive margin'. This indicates 
that there is a high likelihood that part of the tumor was left behind in the breast. The 
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initial step in this tissue assessment process is called gross pathologic examination. In 
certain surgical procedures, gross examination is performed while the patient is still on 
the operating table and is referred to as intraoperative tissue assessment. In breast-
conserving surgery, intraoperative gross pathologic examination of excised breast tissue 
is designed to assist the surgeon in identifying any cancerous tissue not removed from the 
patient, while simultaneously aiming to retain as much healthy tissue as possible. 
Once the tumor has been excised, the surgeon orients the specimen as it was in the 
body using either orientation clips or sutures that correspond to directions in the body. 
For example, a long suture is placed on the tissue side that corresponds to the lateral side 
of the body, a short suture is placed on the superior side, and a medium length suture is 
placed on the medial side. The purpose of maintaining the orientation of the specimen is 
that if a positive margin is identified, it is necessary for the surgeon to know from which 
area of the surgical cavity to remove more potentially cancerous tissue. The specimen is 
then x-rayed to confirm tumor inclusion, as demonstrated in Figure I.3. 
Figure 1.3. Radiographs of excised cancerous breast tissue oriented with (A) sutures 
(Baron, 2000) and (b) clips (Marazzi). 
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Following this, the specimen is given to the pathologist who fully orients the 
tumor by replacing the orientation clips or sutures with six colors of differential ink on 
the areas of specimen corresponding to specific orientation directions: superior, inferior, 
anterior, posterior, medial, and lateral (Figure 1.4). The pathologist then sections, or 
slices, the specimen by hand in order to examine each slice for a healthy margin of at 
least 2 mm. 
Figure 1.4. Differentially inked breast tumor specimen (Pinder, 2005). 
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The process of intraoperative pathologic examination of a typical surgically 
excised tissue specimen is illustrated in Figure 1.5. The entirety of the intraoperative 
margin assessment process takes approximately 25 minutes (Uecker, 2011 ). Because of 
the high cost of operating room time and the added risk of having a patient under 
anesthesia for extended periods of time, we aim to significantly reduce this overall 
processing and assessment time with the introduction of our device. 
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Figure 1.5. The current process of specimen assessment; the steps are (A) using ink 
to orient the whole specimen, B) sectioning of the specimen, and (C) examination of 
specimen sections. 
Limitations of the current gross pathology process 
19 
While there have been many improvements in the microscopic examination of 
tissue (Bankfalvi, 2004) (Cesar, 2007) (Jean-Philippe, 2010), the process of gross 
examination of specimens has remained relatively unchanged for decades. The current 
process of tissue examination leads to user-dependent and non-reproducible results, as 
described by practicing pathologists. Considering the critical importance of intraoperative 
gross examination in clinical outcomes (Uecker, 2011), the lack of improvements to the 
process renders it error-prone. We have identified this lack of improvements as a 
significant current clinical problem. Furthermore, definitive margin status is often not 
available until well after the patient has left the operating room, another factor leading to 
the high percentage of repeat surgeries (Uecker, 2011). Delayed assessment is likely due 
to the fact that (1) some hospitals opt out or do not have the resources for intraoperative 
assessment of tumors and (2) the gold-standard of margin assessment through 
microanalysis takes up to several days (Uecker, 2011). Additionally, hospitals that choose 
to perform intraoperative margin assessment with sub-optimal methods have 
approximately twice the local breast cancer recurrence rates in patients who select breast-
conserving surgery over mastectomy (Atkins, 1972). Specific limitations of current 
intraoperative pathologic examination devices and techniques include: 
1. Inaccurate specimen orientation 
2. Single-plane specimen imaging 
3. Non-reproducible specimen sectioning 
4. Lack of proper specimen fixation 
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Figure 1.6. Process of differential inking of excised tumor specimen. 
Handling errors of breast specimens often lead to frequent issues in breast surgery 
practices (Dooley, 2005). Therefore, it is important to identify and understand all possible 
sources of error. 
Inaccurate specimen orientation 
Specimen orientation is the practice of marking the excised tissue specimen as it 
was oriented in the body prior to surgical removal. The orientation information is of 
critical clinical importance because the presence of cancer in a particular margin of the 
specimen guides the surgeon to remove additional tissue from only the corresponding 
area of the surgical site. This avoids removal of excess healthy tissue, an undesirable 
outcome for patients choosing a breast-conserving treatment option. 
Full specimen orientation is currently accomplished by a process called 
differential inking, in which each side of the excised specimen is dyed in a different color 
as demonstrated in Figure I.6. In the case of breast cancer, the American Society of 
21 
Breast Diseases recommends that specimen orientation be performed by the surgeon in 
the operating room during surgery, since the surgeon has the best perspective on 
orientation (Feldman, 2005). However, in reality, the time-consuming procedure of fully 
orienting a specimen is not done by the surgeon. Rather, the surgeon places several 
orientation clips or sutures (Figure 1.3) and sends the specimen to the pathologist to 
complete the process with inking. 
Single-plane imaging of specimens 
There are no currently-available specimen containers for breast-conserving 
surgery that offer a mechanism for x-ray imaging specimens in two planes. The power of 
two-view x-ray imaging is in revealing additional margin information. This issue is 
exemplified in Figure 1.7(A), in which an image is shown with a tumor at the center of 
the specimen with seemingly adequate margins but, as revealed in Figure 1.7(B), the 
image of the same specimen horizontally reveals a dangerously close margin. At Temple 
University, where these images were taken, the incorporation of two-view radiography 
reduced repeat surgery rates from 12% to 5% (McCormick, 2004). 
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Figure 1.7. X-ray images of a breast specimen: (A) vertical and (B) horizontal 
images of a breast tumor specimen. The bulk of the tumor mass is within the red 
line (McCormick, 2004). 
Non-reproducible specimen sectioning 
A major source of error in gross examination of tissue arises from the irregular, 
non-uniform pattern of cancer growth in tumors, as shown in Figure 1.8. Even once the 
tumor mass is removed, the irregular growths are often present, but cannot be seen with 
the naked eye or standard imaging modalities (Karssemeijer, 1993). 
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The implication of this in gross tumor assessment is that, if sections are not cut 
thinly enough, positive margins may be missed. Standard practice is to section tissue 
specimens serially every 5 mm (Abe, 2000); but, due to the fatty consistency of breast 
tissue and the unreliable method of manually slicing, thin and even sections are not 
always possible. Instead, instability of the tissue during sectioning can result in thick, 
uneven sections that may not allow for identification of positive margins, as illustrated in 
Figure 1.9. Missed positive margins in gross examination, if caught in further assessment 
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steps, lead to repeat surgery and, in unfortunate cases where the margin is not caught at 
all, will likely result in local recurrence. 
Figure 1.8. Radiograph of a breast tumor exhibiting spiculations, at which the red 
arrows are pointing (Smart-Surgery, 2011). 
Figure 1.9. Illustration of missed positive margin (circled in blue) due to instability 
of specimen during current method of sectioning. The black lines indicate where 
sections have been made. 
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One method to avoid missing cancerous margins is intraoperative cryosectioning, 
but the limitation of this technique is that the freezing process introduces artifacts that 
may obscure accurate diagnosis and that may even produce false-positive results 
(Deyanira, 2009) (Shayan, 2004). Additionally, not all medical centers have the 
equipment or expertise available to perform frozen sectioning for each case. 
A more accurate, but significantly more time-consuming approach to margin 
assessment is microscopic analysis of fully-processed tissues by the pathologist after 
surgery. The tissue preparation process consists of the following (Mercer University 
School of Medicine, 2011): 
1. Full fixation of the tissue in 10% formalin for up to 24 hours 
2. Placement of the tissue into processing cassettes for dehydration through cycles of 
alcohol and xylene 
3. Paraffin penetration of the tissue 
4. Microtoming and placement of the tissue sections onto slides 
5. Hematoxylin and eosin staining of the slides 
Once these steps are complete, microscopic analysis can be done by the pathologist. The 
process of specimen sectioning for further microscopic examination is illustrated in 
Figure I.10 below. Due to the number and length of the steps, definitive margin status 
often takes days to determine. 
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Figure 1.10. (A) Manual sectioning of specimen; (B) slices placed in cassettes for 
further examination. 
Lack of proper specimenf,xation 
Tissue fixation is a critical part of tissue processing. Following gross examination 
of the excised tissue, specimen slices are typically wrapped in a paper towel and placed in 
a solution of formalin, as shown in Figure I.11. Generally, tissue fixes in 10% neutral-
buffered formalin at an approximate rate of 1 to 2 mm per hour (Tangella, 2010). 
Because the process of cellular breakdown and decay begins the moment that the tissue is 
removed from the body (University of Washington School of Medicine, 2012), fixative 
penetration is pertinent. 10% formalin is used largely because of its ability to rapidly 
penetrate tissue, however, for thick specimens, autolysis and putrefaction is still likely to 
occur leading to artifacts in the tissue (Specht, 2001 ). The device described in this 
document has been designed in order to minimize tissue thickness, thereby decreasing the 
risk of cellular breakdown before the fixative has penetrated. 
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Figure 1.11. Tissue section is wrapped in a paper towel and placed in a container of 
formalin. 
Current Tools for Intraoperative Margin Assessment 
There are a number of tools being developed to improve the process of 
intraoperative positive margin detection. These tools are largely hand-held fiber-optic 
probes that use varying optical techniques to identify cancerous cells within a ~2 mm 
margin of excised tissue. Mahadevan-Jansen et al. (2011) is developing spatially offset 
Raman spectroscopy (SORS), a method to detect subtle changes in soft tissue spectra in 
the 100-2000 pm range, to be tested on excised breast tissues. In another study, MALDI 
mass spectrometry, a molecular technology that has the specificity and sensitivity to 
monitor and identify cellular changes in renal carcinoma, was successfully used to assess 
differences between a tumor and adjacent normal tissue (Oppenheimer, 2010). Similarly, 
Keller (2010) and Kennedy (2010) took spectral measurements from the surface of the 
27 
breast tissue masses following excision in order to examine the use of autofluorescence, 
diffuse reflectance spectroscopy, and spectral imaging in evaluating margin status 
intraoperatively; Keller et al. were able to identify positive margins with 85% sensitivity 
and 96% specificity. These tools are being designed to optimize detection of cancerous 
margins. In contrast, our device is designed to improve upon the current gross 
examination process itself with the goals of reducing both the excessive removal of 
healthy tissue and the incidences of repeat surgery and local recurrence of cancer. There 
are a number of promising advances being made in this area of intraoperative margin 
assessment, but adoption of these aforementioned tools by the medical community has 
been limited. 
Speaking with physicians from various hospitals around Tucson, we discovered 
that there are two major reasons for limited adoption of many medical tools: cost and 
resistance to change. Hospitals, like all public and private operations, have limited 
budgets; therefore, purchases for new equipment are not made unless deemed necessary. 
Necessity, in this case, refers to the long-term difference the equipment will make on the 
cost of treating a patient. For example, if Equipment X statistically decreases the need for 
repeat surgeries, then the hospital will end up saving money on operating room time, and 
the investment is worthwhile for the facility. Additionally, physicians, like most people, 
are resistant to adopt novel technologies once standard practices have been established 
due to the learning curve associated with new techniques. 
The most comparable tool that is currently being used for intraoperative margin 
assessment is similar to the gel component of the technology that will be described in this 
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report. The Tissue-Tek Optimal Cutting Time (OCT) compound is a water-soluble gel 
composed primarily of polyvinyl alcohol and polyethylene glycol; it is currently being 
used by research facilities worldwide for the purpose of embedding tissues for improved 
speed of frozen sectioning and analysis (Gene Research Lab). The method by which it is 
used is as follows: a tissue section is placed into a specimen block and is then fully 
covered with the OCT compound; the compound infiltrates the tissue and binds it to the 
block at which point the tissue block is placed in liquid nitrogen. The tissue can then be 
thinly and evenly cryo-sectioned and examined for positive margins. Although the use of 
this compound is similar to the one proposed in this document, there are limitations to the 
OCT compound that are addressed by the technology described in this document. 
As mentioned earlier, frozen sectioning, even when done in a controlled manner 
whereby thin and even sections are obtained, is limited by the potential tissue artifacts 
produced during freezing. These artifacts have been found to obscure diagnosis in some 
instances (Deyanira, 2009) (Shayan, 2004). Furthermore, the additional capital equipment 
that is necessary to produce frozen sections is a limiting cost factor in the adoption of this 
technique in hospital settings. 
Keeping in mind the limitations of current practices and tools, we aimed to design 
a device for the purpose of providing a simple, affordable method of intraoperative 
margin assessment that does not requirement significant changes in current practices by 
both the operating surgeon and the pathologist. 
In the following studies, the characteristics and considerations that went into the 
mechanical design of the device hardware will be described in a manner that addresses 
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the limitations of current tumor specimen orientation practices. Following this, the novel 
gel properties and components will be described in detail with emphasis on current 
related applications. Then, three studies involving the testing of specific device properties 
will be reviewed. The first study examines the time needed for various gel formulations 
to set and the maximum temperature reached during this reaction in order to evaluate 
which formulations would be most suitable for intraoperative applications. The second 
study looks into the radiographic properties of the gels and potential plastic materials for 
the hardware for the purpose of eliminating materials that may interfere with x-ray lesion 
assessment. The purpose of the final study is to assess if the gels have any effect on the 
processing and analysis of cancerous tissue. The results of these studies will determine 
the potential for this device to be used in a clinical setting and will lay the foundation for 
future applications. 
30 
II. PROPOSED DEVICE AND PROCEDURE FOR TUMOR SPECIMEN 
PREPARATION 
The aforementioned limitations of current intraoperative gross examination 
methods were first pointed out to us by breast pathologist Dr. Lauren Grasso at the 
University Medical Center. She identified the user-dependence of the process, the 
excessive amount of time that full gross assessment adds to an operation, and the lack of 
significant improvements over decades in the area of gross examination. Dr. Grasso also 
emphasized the substantial resistance to change that is present in her field. Using this 
knowledge of the specific limitations of current practices and the necessity to develop a 
tool that supplements current techniques rather than replaces them, our team, consisting 
of Emre Toker, an electrical engineer, Mark Banister, a polymer chemist, Dr. Grasso, and 
myself, began to design and develop the unique aspects of the device. 
The device consists of two main parts: the hardware and the gel. The gel 
component was contributed by Mark Banister who was in the midst of developing the 
polymer mixture for his company, Medipacs. Its original application was in a swelling, 
hydrogel-based drug delivery system but its properties ofbiocompatibility and rapid 
setting made it optimal for our application; and, as described in future sections, we have 
been able to optimize it for our purposes. The device hardware, on the other hand, has 
gone through several revisions since its original inception. Initially, the design was 
significantly more complicated than the design presented in this report. It contained the 
following features which I have since deemed unnecessary: 
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• A flexible base for the purpose of looking at the tissue specimen sections without 
removing them from their original conformation 
• A sectioned base in which each section ( of approximately 15 in total) could be 
independently removed then replaced following tissue assessment 
• Plastic sectioning guides that attached on each side of the base sections allowing 
for even tissue section thicknesses during slicing 
After conducting more research into the current practices of margin assessment, both 
gross and microscopic, I identified that these features are not only unnecessary but would 
potentially interfere with current tissue processing and assessment methods. The 
specimen sections must be removed from the original conformation in order to analyze 
each section thoroughly for positive margins; additionally, there is no need to replace the 
sections following assessment because the entire tissue section is immediately processed 
for microanalysis. Lastly, any plastic that is in the gel, such as the proposed sectioning 
guides, would have to be removed before processing because plastic cannot be 
microtomed, a necessary step in preparing tissue for microanalysis. Since our initial 
work, I have simplified the structure of the hardware and added functional features that 
address all limitations of assessment practices described previously without interfering 
with processing of the tissue. 
A. Device Hardware 
As described in Section LB., limitations in orientation practices can result in the 
excessive removal of healthy breast tissue, inaccurate margin assessments, and 
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unnecessary repeat surgeries. The device hardware is designed to address the limitations 
associated with orientation of excised tumor specimens. 
The specific purposes of the device hardware are (1) provide useful orientation 
information for the surgeon in the operating room, (2) provide orientation information in 
the radiograph for the physician assessing x-ray tumor inclusion, and (3) provide features 
for the pathologist to maintain orientation through the gross examination process. In 
creating the features of the mechanical design, we went through a number of steps. 
The process began by identifying the optimal shape of the device. Due to storage 
limitations in hospitals, a cubic shape was decided upon. Orientation markings were 
added in a manner that would reflect breast positioning in the operating room; since the 
patient lies horizontally on her back, we designed the top plane, or opening of the cube, 
to correlate with the direction of the nipple. The directionality medical terms ("Superior", 
"Inferior", "Medial", and "Lateral") were embossed on each side wall of the device. In 
order to minimize the amount of change for the surgeon, it was necessary to emulate the 
current orientation practice (Figure 1.3). We added three different length pegs that can be 
seen clearly from above to correlate with the current technique of using three sutures of 
different lengths; the short peg corresponds to the "SUPERIOR" orientation direction and 
the middle and long length pegs correspond to the "MEDIAL" and "LATERAL" 
orientation directions, respectively. The orientation markings and pegs can be seen in 
Figure II. I (A). 
Another concern that pathologists discussed during our interviews was that of 
orientation once the gel is sectioned. In order to section the gel, the hardware walls will 
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be folded down and the orientation markings used by the surgeon would no longer be 
present. The concept of embedding shapes (e.g. circles, triangles, squares) corresponding 
to orientation directions addressed this concern. Once the gel hardens, the hardware will 
have embedded the edges of the gel with pertinent orientation information to the 
pathologist, as illustrated in Figure II. I (C). 
It is necessary to have orientation information available in the radiograph as well 
for the purpose of initial margin assessment. In order to address this need, we have 
integrated markings designed to be visible on an x-ray; an "S" and "L", corresponding to 
'Superior' and 'Lateral', respectively, are present, as shown in Figure II.l(B). In addition, 
we have added a row and column for the purpose of identifying the specific area of the 
tissue in which the mass is present (Figure II.l(B)). Radiographic orientation information 
is also available on the "SUPERIOR" wall, allowing for imaging and orientation in an 
additional x-ray plane. 
As aforementioned, it is necessary for the walls to open and collapse down in 
order to facilitate sectioning, or slicing, of the gel-encapsulated tissue by the pathologist. 
The major difficulty associated with the design of this feature is that the cube cannot be 
designed intact. Due to factors such as cost and mold longevity, we have chosen to create 
a straight-pull mold-a mold that requires mechanical designs in which two halves of the 
mold pull straight away from each other. An example of a straight-pull mold is shown in 
Figure II.2. 
In order to create a design that allows for this type of molding to be done, an 
unfolded cube was created. To allow for re-folding of the cube, very thin (1 mm) plastic 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
\ 
( 
\ 
\ 
34 
was made to connect the walls to the base of the cube (Figure II. l(D)). Once the flat cube 
is injection molded, the walls will be folded up and glued together, giving the device its 
cubic shape. 
A requirement for optimal gross assessment is the sectioning of thin (5 mm) tissue 
slices (Weidner, 2003). From the observation of current practices, it has been noted that 
pathologists use no quantitative method of measuring the sections. We designed 
sectioning marks that are spaced every 5 mm; once the gel hardens, the marks will be 
embedded into the gel, serving as guides for the pathologist to follow (Figure II.l(D)). 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
35 
(C) 
' x..J 
(D) 
Figure 11.1. Different angles of the device hardware mechanical design. The 
following features are visible: (A) the medical orientation markings, (B) x-ray 
orientation markings and top-view pegs, (C) the embedded shapes for orientation of 
the specimen once the hardware is removed, and (D) the 1 mm thin plastic 
connecting the wall to the base and the 5 mm spaced sectioning guides. 
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Step 1 
Step 2 
Step 3 
Figure 11.2. The steps taken to create a straight-pull mold (ProtoMold, 2011). 
In addition to the design parameters necessary for device functionality, it was also 
necessary to take into account the feasibility of mold creation. The device was modeled 
with draft angles of at least 0.5°, a requirement for simple, straight-pull molds. Also, for 
this type of mold, depth of features is limited. Our only deep feature is a centered tissue 
anchor. In our preliminary tests in which we placed tissue into an unhardened gel, the 
tissue, due to a difference in density, floated to the surface of the gel. If this happens in a 
clinical setting, key orientation may be lost. The anchor, see in Figure II.3 with a 5 mm 
diameter base, is designed to pierce into the excised tissue mass, thereby holding it in 
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place until setting occurs. In reality, the anchor will have to be significantly thinner in 
order to pierce the tissue without causing morphological damage to the specimen. The 
anchor will be approximately the thickness of a 12-gauge needle. It has been designed to 
be injection molded separately and then tightly fastened into the cube once molded. In 
order to accomplish this, the base of the device was designed with an elliptical hole 
matching the base of the anchor, shown in Figure II.3(A). Once the tissue anchor is 
placed in the hole, a clockwise tum fastens it in place and two protruding wedges, shown 
in Figure II.3(B), hold the structure in place. It will be necessary to select a material that 
is strong enough to withstand the tissue piercing process without fracture to the anchor. 
We will test this property experimentally once a prototype is ready to be built. 
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(B) 
Figure 11.3. Mechanical design of (A) the independently-molded tissue anchor with 
appropriate draft angles and (B) the device base where anchor is inserted and 
fastened into place. 
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Several features of the hardware are designed to provide support and shape for the 
gel in the steps following initial orientation and radiographic assessment. The next 
section will go into specifics regarding what materials constitute the gel and their uses in 
intraoperative breast cancer examination. 
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B. Device Gel 
Novel properties and current uses 
The novel gel formulation created consists of the following two polymers: 
poly(ethylene glycol) diglycidyl ether and poly(ethyleneimine), with water used as a 
solvent; both polymers are obtained from Polysciences, Inc. Before settling on this 
compound, we tried several other materials including a variety of cyanoacrylates and 
UV-curing resins. The cyanoacrylates set in a manner of minutes but are limited by the 
fact that, when used in volumes greater than 5 ml, the temperature of the reaction was so 
high that the materials could not be handled. Additionally, the hardened materials were 
too rigid to be cut easily by hand. The UV-cure resins are desirable because of their 
ability to cure in less than 1 minute. The major limitations of these materials are (1) in 
order to be utilized for intraoperative applications, additional equipment, a high-powered 
UV lamp, must be introduced to an already space-limited operating room and (2) 
additional work must be done by the operating room staff to ensure full setting of the 
material. In comparison, the combination ofpoly(ethylene glycol) diglycidyl ether and 
poly( ethyleneimine) in water results in an independently and rapidly setting hydro gel that 
is biocompatible and can be easily sliced by hand. 
Poly(ethylene glycol) diglycidyl ether (PEGDE) is a derivative of the 
poly(ethylene glycol) group. This group of polymers has found numerous uses and 
applications due to its water solubility, hydrophilicity, physiological inactivity, low 
toxicity, and stability under varying chemical conditions (Polysciences, Inc., 2007). 
Applications of poly( ethylene glycol) polymers range include industrial practices such as 
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ink solvents and dispersants (Zopes, 2010), separator and electrolyte solvent in lithium 
polymer cells (Lee, 2001), polar stationary phase for gas chromatography (Gu, 2011), and 
surfactants (Kausik, 2011) (Kumar, 2011) as well as medicinal applications such as 
precipitants for plasmid DNA isolation (Baeyens, 1994), virus concentrators (Hitchman, 
2011 ), and stabilization agents for gene therapy vectors such as viral plasmids and 
liposomes (Kreppel, 2007) (Rossi, 2006) (Geisbert, 2010). 
n 0 
Figure 11.4. Chemical structure of poly(ethylene glycol) diglycidyl ether. 
Poly( ethyleneimine) (PEI) is an organic polymer that contains a high density of 
primary amines. Its polycationic nature lends itself to various biological applications such 
as cell attachment promoters (Vancha, 2004), transfection reagents (Rudolph, 2000), and 
as cytotoxicity agents (Moghimi, 2005). When combined with water, the PEGDE and 
PEI crosslink to form a biocompatible, ductile gel that is very suitable for our 
applications. The reaction, shown in Figure 11.6, is the result of the amine groups on the 
PEI bonding with the epoxy groups on the PEDGE creating a highly cross-linked 
hydro gel. The exothermicity of the reaction is due to the breaking of the epoxide rings 
during bonding (Antoniotti, 2004). 
N 
H n 
Figure 11.5. Chemical aminated structure of poly( ethyleneimine ). 
Current applications that use a combination of PEI and the derivative ethylene 
glycol diglycidyl ether are primarily in coatings and applications such as surface-ion 
imprinting (Li, 2011 ), nanoparticle cross-linking ( Goyal, 2011 ), formation of sterically 
stabilized polystyrene latexes (Walsh, 2010), and complex cell-micropatteming 
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(Y amazoe, 2009). Additionally, there has been significant work done in the area of 
hydrogel actuator development. Banister et al. (2007) has designed and tested 
formulations of electroactuated polymer hydrogels for the purpose of controlled drug 
delivery via pump. They found that varying the fraction of reactive components affects 
the hydrolytic instability of the hydro gels, brittleness, and equilibrium swelling ratio. In 
this study, we use a similar method of component variation in order to use the reaction to 
optimize properties for our uses. 
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GE-PEGsoo-GE: n = -9 
Polyethyleneimine 
Figure 11.6. The chemical reaction between the three components of the gel mixture, 
PEI, PEGDE, and H2O. 
It is important to note that gel swelling does occur in the formation ofhydrogels. 
The extent of swelling is dependent on the density of the polymeric mesh where water 
molecules fill the gaps in between the polymer chains. Swelling is therefore dependent on 
variables such as the chain lengths of the polymers and the ratio of the components in 
each formulation. For our purposes, swelling is of little concern due to the structure of 
our hardware; since the top of the device is open, any swelling-induced volume change 
will result in gel translation upwards, with likely no effect on the encapsulated tissue 
specimen. 
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Device gel uses 
The purpose of the gel formulation in this application is to (1) eliminate the need 
for differential inking of specimens by holding orientation information in its shape and 
(2) provide support for the specimen during sectioning. 
As shown in Figure IL 1, the hardware details the specific orientation information 
for the surgeon and pathologist. However, the hardware itself does not keep the specimen 
in its proper orientation. The gel has been designed to be poured into the hardware; then, 
minutes after the specimen has been placed inside by the surgeon in the operating room, 
it sets into a hardened but moderately ductile gel. The entire device with specimen and 
gel can then be radiographed. 
Following radiography, the device is transported to the pathologist. The walls of 
the hardware are folded down and the 5 mm-spaced sectioning guides that are embedded 
in the gel allow the pathologist to cut thin, even slices through the tissue and gel material. 
The sectioning guides coupled with the stability that the gel provides the tissue during 
slicing minimizes risk of missed positive margins, as is illustrated in Figure IL 7. Once the 
specimen margins are evaluated and any additional cancerous tissue is removed from the 
patient, the entire tumor and surrounding gel can be fixed, processed, and 
microscopically analyzed. 
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Figure II. 7. Gel used to stabilize the tissue to allow for thin, even slicing of the 
tumor. A positive margin is identified within the blue circle. 
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The gel property of greatest importance is the time in which it takes the gel to set, 
or harden. The cost of operating time can be upwards of $130 per minute, not including 
extra resources specific to the procedure (e.g. clip for an intracranial aneurysm) or 
surgeon and anesthesia provider fees (Macario, 2010). We are aiming to not only increase 
the accuracy of the examination procedure but also to minimize the amount of time, and 
therefore cost, necessary to determine intraoperative margin status. 
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III. PRELIMINARY TEST RESULTS FOR PROPOSED DEVICE MATERIALS 
We designed a study for the purpose of narrowing down the options for gel 
formulations that would be suitable for intraoperative applications. As aforementioned, 
the function of the gel itself is to ( 1) to keep the specimen in its proper orientation and (2) 
to provide stability to the tissue during sectioning. 
The gel property of greatest interest is the setting time. A major factor that is 
always taken into account in surgical procedures is operating room time, due to both 
patient safety and cost. Because many surgeons opt to get margin assessments of 
lumpectomies intraoperatively, the amount of time that it takes the gel to set is of utmost 
importance. 
Based on our observations of the pathologists' inking and sectioning process in 
the operating room, the current process takes between 10-25 minutes depending on the 
tissue size and consistency, the physician's experience, how the surgeon has oriented the 
specimen, as well as other potential factors. Our device not only aims to remove sources 
of human error, such as multiple persons orienting a specimen, but also to shorten the 
amount of time necessary in the operating room. We aimed to identify the gels with 
properties that would enable this. 
We began by outlining 32 target gel formulations, varying both the volumes of the 
components as well as the chain lengths of the two polymer components, as outlined in 
Table III. I. 
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Table 111.1. Gel formulations with the chain lengths and volumes tested. 
Gel# PEI chain length PEGDE chain PEI (g) PEGDE H20 (g) 
length (g) 
1 1200 526 7 5 6.5 
2 1200 600 7 5.9 7 
3 1200 1000 7 9.5 6.5 
4 1200 600 8.4 5.7 7 
5 1200 1000 8.4 9.5 6.5 
6 1800 526 9.33 5 6.5 
7 1800 600 9.33 5.7 6.5 
8 1800 1000 9.33 9.5 6.5 
9 1800 526 11.6 5 6.5 
10 1800 600 11.6 5.7 6.5 
11 1800 1000 11.6 9.5 6.5 
12 1200 1000 8.4 7.6 6.5 
13 1800 1000 11.6 7.6 6.5 
14 1200 1000 8.4 6 6.5 
15 1800 1000 11.6 6 6.5 
16 800 526 3.5 5 8.5 
17 800 600 3.5 5.7 8.7 
18 800 600 4.2 5.7 8.5 
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19 800 600 3.5 5.7 10. l 
20 800 526 4.2 5 8.5 
21 800 600 4.2 5.7 8.5 
22 800 600 4.2 5 8.5 
23 800 600 5.1 5 10.1 
24 800 600 4.2 5 8.5 
25 1800 600 11.6 4.7 7.6 
26 1200 600 9.3 4.7 7.6 
27 1200 526 8.7 7.5 3.5 
28 1200 600 8.7 5 5 
29 1200 600 8.7 8 3.5 
30 800 600 4 5.7 8.5 
31 800 600 4.5 4.5 8.5 
32 800 600 5 5 8.5 
A plastic bag was placed into a 100 mL beaker in order to prevent the gel from 
sticking to the glass walls. Respective volumes of the components were then added to the 
beaker, PEI being added first followed by PEGDE, and then lastly water. The contents of 
the bag were all stirred for approximately 30 seconds and a timer was started. A 
thermometer was placed into the center of the mixture and the beginning and peak 
temperatures were recorded. Once the gel fully set, as confirmed by manual prodding of 
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the surface, the gel was removed from the beaker and bag then cut in half to confirm the 
center of the formulation was set as well. This was repeated four times for each gel 
formulation. 
The results of the setting times and peak temperatures reached during setting are 
demonstrated in Figure III. I below. 
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(B) Maximum Temp. During Gel Setting 
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Figure 111.1. (A) The total time taken for each gel formulation to set; (B) The 
maximum temperature reached during setting for each respective gel formulation. 
The points represent the average value of 4 trials for each formulation with the 
error bars representing the standard deviation. 
Figure III. l(A) demonstrates the wide range of setting times from approximately 
5-45 minutes. As previously described, the aim is to identify the gels that have the 
potential to shorten the current process of intraoperative assessment; therefore, the gels of 
most interest are those setting under 10 minutes. We identified 11 gels in this range. 
Temperature is a significant factor to note due to the effect of thermal exposure on 
tissue. Notable thermal damage to human tissue varies with both the peak temperature 
and duration of the thermal exposure (Dewhirst, 2003). We estimate that the duration of 
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the peak temperature while setting is no longer than 1 minute therefore the maximum 
temperature that the gel may reach during setting is 54 °C (Moritz, 194 7) (Stoll, 1959). 
Only gel formulation #20 reported peak temperatures above the threshold for tissue 
damage. 
We also used the data to compare how setting time correlates to the peak 
temperature reached when the mixture is reacting. We found that there is a negative 
correlation; as the setting time increases, the peak temperature reached decreases, as 
illustrated in Figure III.2. 
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Figure 111.2. Correlation between gel setting times and respective peak temperatures 
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We hypothesized that the setting time is affected by the total volume of the gel 
mixture due to the decreased ratio of surface area to unit of gel as the total volume 
increases; as the ratio decreases, heat exchange also decreases. Therefore, it is likely that 
the temperature of the reaction, and subsequently the setting time, will change with 
volume. We tested this by preparing a fast-setting gel, #16, at four different volumes and 
monitoring the temperature profiles at various time points. The formulations were mixed 
together by the same method as the previous setting time experiments with ratiometric 
increases in volume. The results are presented in Figure III.3. We found that as the total 
volume of gel decreases, the maximum temperature reached decreases and the setting 
time increases. 
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Figure 111.3. The effect of volume on the temperature profile and setting time of gel 
formulation #16. The large point in each set indicates the time of gel setting. 
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Because there is variation in the size of excised lumpectomies (Kearney, 1995), 
there may be need to use different formulations for different sizes in order to ensure 
optimal set times with no thermal damage. The gel tested in Figure III.2 is not suitable for 
larger specimen volumes due to the potential thermal damage that could be caused during 
gel setting. We chose to examine other options for larger specimens. We tested two 
additional 200 ml formulations, #13 and #32, both of which had initial set times of over 
15 minutes. In an effort to decrease the maximum temperature of the reaction, we also 
tested gel #16 again but changed the order in which we mixed the components together. 
We observed that mixing H20 and PEI together caused an exothermic reaction, emitting 
heat; this is likely due to protonation of the PEI amine groups (American Chemical 
Society, 2011). We therefore mixed these components together first, waited one minute, 
and then stirred in the PEG DE. The formulations' temperature profiles are plotted against 
time in Figure III.4. 
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Figure 111.4. The effect of volume on the temperature profile and setting time of gel 
formulation #16. The large point in each set indicates the time of gel setting. 
Although setting very rapidly, gels #16 and #32 reached temperatures that are 
potentially damaging to tissues and therefore could not be used for specimens of this 
volume. Gel #13 peaked at relatively low temperature of 42°C but it undesirable due to 
the length ofreaction time. As predicted, Gel # 16 with pre-mixing of H2O and PEI, 
resulted in a slowed setting time of approximately 6 minutes, with a temperature that is 
suitable for tissue viability. These findings indicate that different gel formulations may be 
suitable for different volume applications and also that specific gel reactions can be 
slowed by changing the order in which the components are mixed. 
In reality, the temperature reached during the reaction is not likely to present 
limitations for our device in this proposed application. High thermal exposure to the 
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surface of the excised tissue sample may cause apoptosis or necrosis to the first few 
layers of cells but tissue morphology would remain intact and cancerous margins could 
still be recognizable both grossly and through microanalysis. To test this in the future, we 
will place cancerous tissue into gels that reach increasingly higher temperatures during 
setting and then we will process, stain, and analysis the tissue to determine whether the 
cancerous morphology can be recognized through any potential thermal damage that 
occurs to the surface cell layers. If we are able to show that temperature is not a 
limitation, then we will be able to use significantly faster setting gels (<3 minutes) to 
further minimize time spent in the operating room. 
IV. X-RAY ABSORBANCE OF DEVICE HARDWARE AND GEL 
Intraoperative radiography of excised breast tumor specimens is a standard 
practice for evaluating tumor inclusion (McCormick, 2004). Therefore, it is necessary 
that any device used in this process not interfere with the physician's ability to identify 
cancerous lesions. 
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We identified 12 target gel formulations of varying properties and prepared them 
in order to examine the x-ray absorbance of each gel. We prepared and cut the gels into 
wedges and placed them onto a Siemens Inveon MicroCT with the image acquisition 
parameters provided in Figure IV.l(A). The MicroCT was calibrated to Hounsfield units 
(HU) using water samples that yielded an expected value of 1 HU. We then used Inveon 
Research Workplace software to reconstruct the image using the parameters in Figure 
IV.l(B). The final reconstructed image is shown in Figure IV.2 below. 
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Figure IV.1. Screenshots of (A) image acquisition protocol used to obtain all 
MicroCT images and (B) the parameters used to reconstruct the MicroCT images. 
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Figure IV.2. The reconstructed MicroCT image of the gels using 3D Visualization 
software by Visage. 
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We selected a spherical Region oflnterest (ROI) with a volume of 72.9 mm3 in 
which the voxel values were shown in Houndsfield units (HU); the HU values for each 
voxel within the ROI was averaged and recorded. Figure IV.3 illustrates the process of 
selecting an ROI within each sample. The resulting averaged HU values are presented in 
Table III. I . 
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Figure IV.3. Screenshot of the process of selecting the spherical ROI and positioning 
it within each gel sample using the three-dimensional view provided by Inveon 
Research Workplace software. 
Table IV.1. Avera ed Hounsfield unit values for each ima ed el. 
Gel# HU 
4 153.4 
19 146.2 
20 161.5 
8 105.2 
16 105.2 
17 123.2 
5 184.3 
13 117.4 
26 190.4 
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The HU values for the group of gels range from approximately 105-190 HU, a range 
close to that of soft tissues (GE Heathcare, 2011). Due to the narrow range between the 
gels and the similarity to the values of tissue, any of the formulations may be used in the 
device based on only this property. 
Given that the hardware will be radiographed along with the gel, it was important 
to collect x-ray absorption data for potential plastics that will be used in the device. We 
collected a set of samples from a local Tucson rapid prototyping facility then scanned the 
group of samples with the same parameters as the gels above. The reconstructed image is 
shown in Figure IV.4. 
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Figure IV .4. The reconstructed MicroCT image of the plastic samples using 3D 
Visualization software by Visage. 
For analysis of the x-ray absorbance of the plastic samples, we selected a cubic 
ROI ofa volume 50.1 mm3, as illustrated in Figure IV.5. The averaged voxel values in 
HU are presented in Table IV.2. 
60 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
( 
\ 
( 
( 
( 
( 
~ 
( 
\ 
( 
( 
( 
Figure IV.5. Hardware sample plastics MicroCT reconstruction in (A) 3D 
Visualization and (B) Inveon Research Workplace with selected the ROis 
highlighted. 
Table IV.2. Averaged Hounsfield unit values for each imaged plastic sample. 
Plastic characterization HU 
LS Duraform HST 932.4 
SLS FR-106 1271.5 
SLS NyTek 1200 CF -183.2 
SLS Nylon 12 AF 443 .9 
SLS NyTek 1100 -192.2 
SLS NyTek 1100 B -36.2 
SLS Nylon 12 GF 782.7 
SLS Nylon 12 -235.7 
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SLA /Half 298.8 
SLA Accura 50 358.2 
SLA SC 4500 399.1 
SLA SC 1000 344.7 
Vero White -38 
Clear -76.5 
Vero Blue -1.9 
The HU values of the various plastics vary significantly, covering spectrums from 
gases to soft tissue to cancellous bone (GE Heathcare, 2011). This data is useful in 
determining which plastics will be suitable for the device. Generally, as x-ray absorbance 
decreases, likelihood of signal interference is reduced, making materials better suited for 
our application; SLS NyTek 1200 CF, SLS NyTek 1100, and SLS Nylon 12, with values 
of less than 1 HU are of greatest interest for future testing with tissue. 
As described previously, the HU values in Tables IV.1 and IV.2 were acquired for 
the purpose of assessing whether the device has the potential to interfere with the 
physician's ability to identify cancerous lesions. The most common method by which 
lesions are found using radiography is by identifying highly x-ray attenuating 
calcifications, a common feature of breast cancers (D'Orsi, 1991). Figure IV.6 below 
illustrates the HU ranges of the device gel and hardware in comparison to those of tissue 
and calcifications. 
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Figure IV .6. Comparison of the HU values of the gels and hardware with tissue and 
calcifications. Each point and its error bars are the average and standard deviation, 
respectively, of the values obtained. 
The most important factor to note in this graph is the high HU values of the 
calcifications. Ifwe couple any of the gels with plastics of radiodensity values of less 
than 1 HU, there is a significant gap between the device values and even the least x-ray 
absorbing calcifications. This supports the hypothesis that the device will very unlikely 
interfere with the assessment of cancerous lesions in the breast tissue using radiography. 
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V. PRELIMINARY TEST RESULTS ON CANINE TUMORS 
One of the most important features to test with this device is any possible effect 
on down-stream tissue processes. If the gel interferes with the fixation, dehydration, 
paraffin penetration, or subsequent staining of the tissue, the results of margin assessment 
may be compromised. We designed a set of experiments to assess what, if any, effects the 
gel formulations have on these processes. 
We acquired fresh samples of cancerous canine tumor tissue within 30 minutes of 
surgical excision. The tumor was approximately 5 cm3 in volume, which we cut into 5 
approximately equal sections, as illustrated in Figure V.1 . One section was placed 
directly into a labeled 10% neutral buffered formalin container as a control and the 
remaining 4 sections were used for gel testing. 
Figure V.1. Photograph of the canine tumor being sectioned by the veterinarian into 
5 test samples. 
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We chose four gel formulations with the fastest setting times: #9, #16, #18, and 
#20 (components and respective quantities are presented in Table III.1) and prepared 
them ahead of time in the following manner; the PEGDE was mixed with water in a 100 
mL plastic vial and the PEI was measured and kept in a separate vial, as shown in Figure 
V.2(A). 
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Figure V.2. (A) The right vial is the PEGDE which was added to the left vial 
containing PEI and water; (B) photograph of the tissue samples submerged in the 4 
test gels during setting. 
We poured the #9 PEI vial into the PEGDE/water vial and stirred together for 
approximately 30 seconds. We then submerged one of the tissue samples into the gel and 
waited for the formulation to set. Once setting was confirmed by prodding the gel 
surface, the tissue was cut from the gel and any surrounding gel was peeled from the 
tissue surface. The tissue sample was then placed into a 10% neutral buffered formalin 
container overnight. This was repeated for the remaining three formulations . 
Observations of the gels during setting were recorded and are presented in Table V.l 
below. 
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Table V.1. Observations of gels containing tissue samples during and after setting. 
Gel# 
9 
16 
18 
20 
Comments 
Set quickly (within 10 minutes), relatively easy to remove 
from the tissue sample after setting 
Set quickly (within 10 minutes), relatively easy to remove 
from the tissue sample after setting 
Very viscous and never set (after 5 hours of observation); 
tissue was removed and placed in formalin after 1.5 hours 
Set within 10 minutes but consistency was very gooey and 
sticky, difficult to separate from tissue sample 
After leaving in formalin overnight to ensure full fixation, all five samples were 
removed from their respective containers. Each tissue sample was placed into a tissue 
processing cassette and labeled with the gel formulation number or "Control" and the 
date. 
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The tissue cassettes were taken to the Arizona Vet Diagnostics Laboratory in 
Tucson, AZ and run through the standard tissue processing procedure (see Appendix). 
The samples were then hematoxylin and eosin stained and a veterinary pathologist with 
over ten years of experience assessed the following properties of the tissue slides, 
specifically comparing the control and the gel-encapsulated tissue samples: abruptness of 
keratinization, cell morphology and organization, chromatin patterns, basal membrane 
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and dermal collagen appearance, and the distinction between basophilic and eosinophilic 
areas. The resulting tissue images are shown in Figure V.3 below. 
Figure V.3. Images of canine cancerous tissues following processing and staining; 
(A) control and gels (B) #19, (C) #20, (D) #16, and (E) #18. 
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The pathologist, Dr. Sharon Dial of the Arizona Veterinary Diagnostic 
Laboratory, determined that the stained tissue properties of the gel-encapsulated samples 
appear indistinguishable from the control sample. This confirms that the gel formulations 
have no effect on tissue properties and therefore may be used in clinical applications. 
VI. CONCLUSIONS AND FUTURE WORK 
The overall purpose of the studies described in this document was to find a 
starting point for clinical testing of the device. In order to accomplish this, it was 
necessary to design the device in a manner that addresses all fundamental limitations of 
current practices as well as to test the gel component for any potential interference with 
tissue properties. 
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We designed a hardware component that addresses the needs for accurate 
orientation of excised breast cancer tissue specimens. We were able to narrow down our 
pre-determined list of gels based on a limited allowance for setting time in the operating 
room and the maximum thermal threshold of tissues. Gels of interest set between 5-10 
minutes and reach a maximum temperature of under 54°C. Since the setting times of the 
gels are dependent on several variables including volume of the formulation and order of 
component mixing, it is necessary to do further testing on the various formulations at 
different volumes. For initial clinical testing, however, we will be aim to work with 
tumor specimens of~ 2 cm in diameter therefore the gels setting in under 10 minutes in 
Figure III. l(A) are of greatest interest. 
Our MicroCT data confirmed that the x-ray absorptive properties of the gel are 
similar to that of tissues, highly minimizing any chance of artifacts that may inhibit a 
physician's ability to identify a lesion on a radiograph. 
Obtaining tissue data was a cornerstone in this research. Confirmation that the gel 
does not in any way affect the tissue processing, staining, and microscopic analysis of 
tumor tissue successfully addresses the fundamental question as to whether it may be 
used in a clinical setting at all. 
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The next stage of this project is the preparation for clinical studies. Following 
setting time, a major purpose of the gel is to provide support for tissue sectioning. The 
way in which we will determine the best gel for this is by making the ten most promising 
formulations with tissue and allowing a random sampling of pathologists to slice each 
and determine the one of greatest interest. Additionally, we will test the sliceability of the 
gels for sectioning on a microtome, a step in the microanalysis of tumor margins. Similar 
to the OCT compound described in "Current Tools" (p. 28), the device gel polymers may 
have the potential to penetrate tissue in a manner that eliminates the need to embed the 
samples in paraffin, a process that takes hours to complete. This property will be tested 
by placing thin (5 mm) tissue sections into the gel in a specimen block then assessing 
whether the microtome was able to cut through the gel and tissue block in a manner that 
facilitates microscopic examination of slides. 
Once we have isolated the most promising formulations, we will make a rapid 
prototype from the mechanical drawings. Due to the volume of samples available through 
our veterinary partners, we will conduct our first clinical study using canine cancerous 
tissue. The goal is to show significant improvement in margin analysis by assessing 
changes in number ofrepeat surgeries as well as the long-term incidence oflocal 
recurrence. Additionally, we will collect information regarding the usefulness of the 
hardware markings, ease of gel and tissue slicing, total assessment time, and any 
unforeseen complications associated with device use. 
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Meanwhile, it is important to understand more of the specific properties of the gel 
formulations and what variables affect characteristics such as set time, temperature, 
ductility, and paraffin penetration. We will design a study to examine the effect of 
polymer chain lengths and the ratio of the three gel components on each of these 
characteristics. 
In developing this technology and describing it to physicians, we discovered that 
it has applications in other surgical cancer types. Specifically, these cancer types, listed in 
Table VI.1, use the same tissue sectioning process for margin assessment either intra- or 
post-operatively. Once we optimize the device for applications in breast cancer, we will 
begin developing devices for other indications, taking into account size and orientation 
specifications. 
Table VI.1. A list of cancers, the average size of the target organ, and any known 
"d f f d d . COOSI era rnns or ev1ce es12n. 
Disease Avg. Organ Considerations 
Volume (cm3) 
Breast 560 Higher adipose content therefore longer fixation necessary 
Prostate 60 Sectioning only for radical prostatectomy 
Melanoma of skin 3 Intra-operative preferred but frozen sectioning distorts cells 
Thyroid 10 Partial resections common 
Lung 6000 For lobectomies, margins are performed intra-operatively 
Kidney 216 If partial nephrectomy, intra-operative margins are evaluated 
Corpus uteri 94 Necessary to evaluate depth of invasion of tumor 
Pancreas 5 
Oral cavity & pharynx 300 Large variations in volume possible 
Liver 3900 Partial resection is common 
Ovary 9 
Testis 20 
Bladder 600 Pre-sectioning expansion of organ necessary 
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Through the studies presented in this document, we have shown a unique and 
useful solution to address the need for standardized gross pathology assessment in breast 
cancer treatment. We believe that the implementation of our device will result in 
significantly improved statistics of repeat surgery incidence and local recurrence rate and, 
as a result, will make breast-conserving surgery a viable and desirable option for 
hundreds of thousands of women worldwide. 
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APPENDIX 
Tissue Processing Protocol 
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